Applied Health Economics and Health Policy

A Review of Recent Decision-Analytic Models Used to Evaluate the Economic Value of Cancer Treatments

A Review of the Challenges of Using Biomedical Big Data for Economic Evaluations of Precision Medicine

General Trends in Prices and Prescription Patterns of Anticonvulsants in Germany between 2000 and 2017: Analysis of National and Cohort-Based Data

ReCell® Spray-On Skin System for Treating Skin Loss, Scarring and Depigmentation after Burn Injury: A NICE Medical Technology Guidance

Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukaemia

Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition

An Alternative Approach to Decomposing the Redistributive Effect of Health Financing Between and Within Groups Using the Gini Index: The Case of Out-of-Pocket Payments in Nigeria

Costs of Mental Health Services in Czechia: Facilitating an Evidence-Based Reform of Psychiatric Care

Treatment Patterns, Overall Survival, and Total Healthcare Costs of Advanced Merkel Cell Carcinoma in the USA

Price Models for Multi-indication Drugs: A Systematic Review

Mepilex Border Sacrum and Heel Dressings for the Prevention of Pressure Ulcers: A NICE Medical Technology Guidance

Universal Mental Health Interventions for Children and Adolescents: A Systematic Review of Health Economic Evaluations

Expanding the Role of the Patient-Centered Outcomes Research Institute: Reauthorization and Facilitating Value Assessments

Health Insurance in Sub-Saharan Africa: A Scoping Review of the Methods Used to Evaluate its Impact

Cost-Effectiveness of Therapeutic Use of Safety-Engineered Syringes in Healthcare Facilities in India

Cost-Effectiveness of Dementia Care Mapping in Care-Home Settings: Evaluation of a Randomised Controlled Trial

Cost-utility Analysis of Opportunistic and Systematic Diabetic Retinopathy Screening Strategies from the Perspective of the Brazilian Public Healthcare System

Improving Decision-Making Processes in Health: Is It Time for (Disease-Specific) Reference Models?

Financial Burden of Prescribed Medicines Included in Outpatient Benefits Package Schemes: Comparative Analysis of Co-Payments for Reimbursable Medicines in European Countries

Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration Project

Vaccination: Is There a Place for Penalties for Non-compliance?

Cost-Effectiveness of a School-Based Social and Emotional Learning Intervention: Evidence from a Cluster-Randomised Controlled Trial of the Promoting Alternative Thinking Strategies Curriculum

Comment on: “Projections of the Healthcare Costs and Disease Burden due to Hepatitis C Infection Under Different Treatment Policies in Malaysia, 2018–2040”

Thopaz+ Portable Digital System for Managing Chest Drains: A NICE Medical Technology Guidance

Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma

Correction to: Use of Expert Judgement Across NICE Guidance‑Making Programmes: A Review of Current Processes and Suitability of Existing Tools to Support the Use of Expert Elicitation

Comment on: “Cost Effectiveness of Dialysis Modalities: A Systematic Review of Economic Evaluations”

The Evolution of Mental Health in the Context of Transitory Economic Changes

The Costs of Hepatitis C by Liver Disease Stage: Estimates from the Veterans Health Administration

Authors’ Reply to Mintz: “Economic Implications of Pathogen Reduced and Bacterially Tested Platelet Components: A US Hospital Budget Impact Model”

Analyzing the Financial Sustainability of User Fee Removal Policies: A Rapid First Assessment Methodology with a Practical Application for Burkina Faso

A Systematic Review of Productivity in Economic Evaluations of Workplace Interventions: A Need for Reporting Criteria?

Budget Impact Analysis of Cancer Screening: A Methodological Review

Cost-Effectiveness of Extended and One-Time Screening Versus No Screening for Non-Valvular Atrial Fibrillation in the USA

The Impact of Ghana’s National Health Insurance on Psychological Distress

Implicitly Estimating the Cost of Mental Illness in Australia: A Standard-of-Living Approach

Forecasting Ontario Oncology Drug Expenditures: A Hybrid Approach to Improving Accuracy

Cost Effectiveness of Secukinumab Versus Other Biologics and Apremilast in the Treatment of Active Psoriatic Arthritis in Germany

What Does Society Value About Cancer Medicines? A Discrete Choice Experiment in the Belgian Population

Public Health Impact and Cost-Effectiveness of Non-live Adjuvanted Recombinant Zoster Vaccine in Canadian Adults

Estimating Attribute-Specific Willingness-to-Pay Values from a Health Care Contingent Valuation Study: A Best–Worst Choice Approach

Acknowledgement to Referees

Real-World Cost Effectiveness of Mandatory Folic Acid Fortification of Bread-Making Flour in Australia

Incorporating the Environmental Impact into a Budget Impact Analysis: The Example of Adopting RESPIMAT® Re-usable Inhaler

The Relevant Perspective of Economic Evaluations Informing Local Decision Makers: An Exploration in Weight Loss Services

Willingness to Pay for Cataract Surgeries Among Patients Visiting Eye Care Facilities in Dhaka, Bangladesh

Developing Attributes and Attribute-Levels for a Discrete-Choice Experiment: An Example for Interventions of Impulsive Violent Offenders